menu
    • menu

    Company profile for Voyager Therapeutics, Inc

    NEW Drugs in Dev: 10
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Voyager Therapeutics is committed to people living with severe neurological diseases. We plan to develop life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (A...
    Voyager Therapeutics is committed to people living with severe neurological diseases. We plan to develop life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS) called SOD1, Huntington’s disease, Friedreich’s ataxia, Alzheimer’s disease, and other neurodegenerative diseases related to defective or excess aggregation of tau and alpha-synuclein protein in the brain.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Voyager Therapeutics, IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    75 Sidney St. Cambridge, MA 02139
    Telephone
    Telephone
    +1-857-259-5340
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.voyagertherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/voyager-therapeutics-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VoyagerTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Voyager Jettisons Staff, Novartis Hands Back 2 Programs
    Voyager Jettisons Staff, Novartis Hands Back 2 Programs

    18 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/voyager-jettisons-30-employees-novartis-hands-back-rights-2-programs

    FIERCE BIOTECH
    18 Dec 2025
    Share Share
    Voyager Throws 30 Staff Overboard After Novartis Sinks 2 Programs
    Voyager Throws 30 Staff Overboard After Novartis Sinks 2 Programs

    18 Dec 2025

    // BIOSPACE

    https://www.biospace.com/business/voyager-throws-30-staff-overboard-after-novartis-sinks-two-programs

    BIOSPACE
    18 Dec 2025
    Share Share
    Transition Bio & Voyager Therapeutics Partner To Target ALS, FTD
    Transition Bio & Voyager Therapeutics Partner To Target ALS, FTD

    14 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/biopharma/transition-bio-and-voyager-therapeutics-forge-strategic-collaboration-to-target-als-ftd-18242

    INDPHARMAPOST
    14 Nov 2025
    Share Share
    Voyager Unveils Q3 2025 Financial And Operating Outcomes
    Voyager Unveils Q3 2025 Financial And Operating Outcomes

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184535/36461/en/Voyager-Reports-Third-Quarter-2025-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Voyager to Present at Upcoming Investor Conferences
    Voyager to Present at Upcoming Investor Conferences

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139119/36461/en/Voyager-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Voyager Reports Strong Q2 2025 Financial and Operating Results
    Voyager Reports Strong Q2 2025 Financial and Operating Results

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128626/36461/en/Voyager-Reports-Second-Quarter-2025-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search